Clik here to view.
武田薬品がアイクルシグ（ポナチニブ）のピボタル第2相PACE試験から得た最終データのブラッド誌掲載を発表
米マサチューセッツ州ケンブリッジ & 大阪 （ビジネスワイヤ） — 武田薬品工業株式会社(TSE: 4502)は本日、難治性の慢性骨髄性白血病（CML）またはフィラデルフィア染色体陽性急性リンパ芽球性白血病（Ph+...
View ArticleClik here to view.
サンバイオ：再生細胞薬「SB623」の開発進捗総括の更新について
東京 （ビジネスワイヤ） — 平成30年３月13日付リリース『再生細胞薬「SB623」の開発進捗総括の更新について』に記載した「SB623」の開発の進捗に動きがあり、これに伴い一部の内容を更新しました。更新箇所は下線の部分であります。 記...
View ArticleClik here to view.
SanBio: Update on Development Progress of Regenerative Cell Medicine SB623
TOKYO The SanBio Group (SanBio Co., Ltd. and subsidiary SanBio Inc.) (TOKYO:4592) has updated part of its March 13, 2018 release “Update on Development Progress of Regenerative Cell Medicine SB623”....
View ArticleClik here to view.
MOLOGEN AG: Collaboration with licensing partner ONCOLOGIE gains momentum
BERLIN The biopharmaceutical company MOLOGEN AG announced today that the collaboration with ONCOLOGIE, agreed on in February 2018, is making good progress. The collaboration includes a license...
View ArticleClik here to view.
Helsinn Investment Fund, Bio Capital Impact Fund and Windham Venture Partners...
JERUSALEM NovellusDx, the leader in functional genomics, today announced it has completed an equity financing of $6 million. The financing round is with the participation of Helsinn Investment Fund...
View ArticleClik here to view.
继美国和英国之后，中国向Personalis, Inc.签发ACE©技术专利，扩大了其在国际上的知名度
加州门罗帕克 (美国商业资讯) — Personalis, Inc.是一家面向免疫肿瘤学的高级基因组测序和分析提供商，公司今天宣布，中国国家知识产权局已签发了ACE©技术平台的专利，专利编号为ZL 2013 8...
View ArticleClik here to view.
Jupl Safety Watch Goes Retail
AUCKLAND, New Zealand & SYDNEY Jupl uses the Samsung Gear S3 watch in conjunction with its own cloud-based monitoring and analytics system. This, in collaboration with Spark and Cisco Jasper,...
View ArticleClik here to view.
Octapharma在世界血友病联盟2018年世界大会上呈报Nuwiq®造福血友病A患者的新数据
瑞士拉亨 (美国商业资讯) – Octapharma今天宣布，Nuwiq®造福血友病A患者的新数据在英国格拉斯哥召开的世界血友病联盟(WFH) 2018年世界大会的一次研讨会上呈报。Nuwiq® 是第四代人类细胞系衍生的重组FVIII (rFVIII)，获准用于预防和治疗所有年龄段血友病A患者的出血发作。此次研讨会名为“进一步满足临床需求：来自Nuwiq®▼（simoctocog...
View ArticleClik here to view.
Clik here to view.
大样本研究有史以来首次揭示遗尿症的遗传学病因
瑞士圣普雷 (美国商业资讯) — 来自于世界上首次全基因组关联研究(GWAS)的新证据确认了遗尿症相关的基因和基因变异，并有望较早确认遗尿症易感儿童和改善较早期治疗选择。2018年5月29日世界遗尿日，国际儿童控尿学会(ICCS)和欧洲儿童泌尿科学会(ESPU)呈报了上述结果。 奥胡斯大学医院儿童青年科肾脏泌尿组教授Søren...
View ArticleClik here to view.
大規模研究が夜尿症の遺伝的原因に初めて切り込む
スイス・サンプレ （ビジネスワイヤ） — 世界初のゲノムワイド関連解析（GWAS）から得られた新たな証拠は、夜尿症と関連する遺伝子や遺伝的変異を特定し、夜尿症になりやすい小児の早期発見と早期治療選択肢の改善をもたらし得るものです。解析結果は2018年5月29日の世界夜尿症デーで、国際小児禁制学会（ICCS）と欧州小児泌尿器科学会（ESPU）が発表を行います。 オーフス大学生物医学科のJane...
View ArticleClik here to view.
FORMA Therapeutics and HitGen Initiate Multiyear Research Collaboration
WATERTOWN, Mass. & CHENGDU, China FORMA Therapeutics and HitGen Ltd. today announced a multiyear research collaboration and license agreement to build and screen proprietary DNA-encoded...
View ArticleClik here to view.
DiaCarta Named to CIO Applications’ “Top 25 Life Sciences Technology Vendors...
FREMONT, Calif. CIO Applications has chosen DiaCarta as one of the Top 25 Life Sciences Technology Vendors 2018. The positioning is based on an evaluation of DiaCarta’s specialty in personalized...
View ArticleClik here to view.
Pharnext Announces PXT3003 was Granted Priority Review by the China Food and...
PARIS Regulatory News: Pharnext SA (Paris:ALPHA) (FR0011191287 – ALPHA), a biopharmaceutical company pioneering a new approach to the development of innovative drug combinations based on big genomic...
View ArticleClik here to view.
Emmanuelle Charpentier博士らのCRISPR/Cas9技術基本特許：日本において成立
ダブリン、アイルランド （ビジネスワイヤ） –ERS Genomicsは本日、日本の特許庁が、ERS Genomicsの共同設立者であるEmmanuelle Charpentier博士とカリフォルニア大学とウィーン大学により共同で出願された遺伝子編集のための1本鎖gRNA形式によるCRISPR /...
View ArticleClik here to view.
Japanese Patent Office Grants Broad Claims Covering CRISPR/Cas9 Gene Editing...
DUBLIN ERS Genomics announced today that the Japanese Patent Office has granted Dr. Emmanuelle Charpentier, ERS Genomics’ co-founder, together with the University of California and University of...
View ArticleClik here to view.
Alteogen and Lynkogen Enter into an Exclusive Option Agreement to Develop...
DAEJEON, Korea & EAST WINDSOR, N.J. Alteogen Inc. (KOSDAQ:196170) and Lynkogen Inc. today announced that they have entered into an exclusive option agreement for the development of Alteogen’s...
View ArticleClik here to view.
JPND and NIH Awards to Support New Transatlantic Collaborations
PARIS Two major research funding entities in the EU and US are joining forces for the first time to optimise and harmonise research into neurodegenerative diseases. The EU Joint Programme on...
View ArticleClik here to view.
Sonic Healthcare Selects Translational Software’s Pharmacogenomics Platform...
BELLEVUE, Wash. Translational Software®, Inc. (TSI), a global leader in the intelligent use of genetic data for clinical decision support, has finalized an agreement with Sonic Genetics, a member of...
View ArticleClik here to view.
Quantapore Inc. Closes Series 3 Financing Round to Fund Beta Launch of DNA...
MENLO PARK, Calif. Quantapore Inc. announced the completion of a $15.55 million sale of Series 3 Preferred Stock led by Northern Light Venture Capital (NLVC). Tsingyuan Ventures and Sangel Venture...
View Article